1Wolf IH,Cerroni L,Kodama K,et al.Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod.Arch Dermatol 2005;141(4):510-514.
2Jaissle GB,Ulmer A,Henke-Fahle S,et al.Suppression of melanoma-associated neoangiogenesis by bevacizumab.Arch Dermatol 2008;144(4):525-527.
